Handling of GYN cancer diagnosis disclosure important

This article originally appeared here.
Share this content:
Communication Factors Aid Cancer Diagnosis Disclosure
Communication Factors Aid Cancer Diagnosis Disclosure

(HealthDay News) -- Ensuring disclosure of a gynecological cancer diagnosis takes place in a private setting and that the conversation lasts for more than 10 minutes improves patient satisfaction, according to a study published online Oct. 7 in Obstetrics & Gynecology.

Lindsay M. Kuroki, M.D., from the Washington University School of Medicine in St. Louis, and colleagues surveyed 100 gynecologic oncology patients (between December 2011 and September 2012) using an 83-item tool based on evaluated patient-centered factors, physician behavior and communication skills, and environmental factors.

The researchers found that 24 percent of patients were notified of their diagnosis by phone, 60 percent in the physician's office, and 16 percent in the hospital. Results were reported by either an obstetrician-gynecologist (58 percent), gynecologic oncologist (26 percent), primary care physician (8 percent), or other (8 percent). A support person was present for 52 percent of patients. Face-to-face disclosure, a private setting, and duration of the encounter of greater than 10 minutes were associated with higher patient satisfaction scores. When adjusting for other factors, both physician communication skills and patient-centered factors (including perception of physician sensitivity and empathy, opportunities to ask questions and express emotion, and setting the pace of conversation) were also associated with higher patient satisfaction.

"Effective physician communication skills and patient-centered factors resulted in higher patient satisfaction with the gynecologic cancer diagnosis disclosure experience," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs